Senior Business Development Consultant | IVD M&A & ODM Partnerships (Multiplex Antigen)

Title: Senior BD Consultant | IVD M&A & ODM Partnerships (Multiplex Antigen) Project Overview We are an established, ISO 13485 and KGMP-certified in-vitro diagnostics (IVD) manufacturer. We have developed a breakthrough point-of-care respiratory antigen test that successfully detects COVID-19, Influenza A, Influenza B, and RSV concurrently on a single cassette. This capability completely surpasses current market leaders (such as BD Veritor Plus and Quidel Sofia 2), which are limited to 3-plex and require separate cassettes for RSV. Our go-to-market strategy is strictly B2B. Rather than building a direct-to-clinic sales force, we are exclusively seeking a high-value ODM, exclusive licensing, or M&A agreement with a Tier-1 global diagnostics firm. We want to leverage a major buyer's existing US distribution, installed reader base, and FDA regulatory machine. Ideal Candidate Profile We need a seasoned deal-maker who has navigated these exact waters before. The ideal consultant or executive must have: - Proven Deal Experience: Direct leadership or senior involvement in at least ONE of the following: an OEM/ODM lateral flow partnership with a top-10 global diagnostic company (e.g., Danaher, Roche, Abbott, QuidelOrtho, bioMérieux), a high-value exclusive technology licensing agreement, or an M&A exit ($50M+) for a rapid antigen company. - Deep Domain Knowledge: A thorough understanding of FIA / lateral flow multiplex technologies and the competitive landscape. - Deal Economics Mastery: Expertise in structuring diagnostics OEM agreements, including royalty rates, minimum volume commitments, and upfront fees. - Strategic Insight: An understanding of the "buy vs. build" criteria used by Tier-1 buyers, along with baseline knowledge of CLIA Waiver and FDA 510(k) pathways (we have dedicated regulatory counsel, but you must know the landscape). - Geographic Advantage: Experience evaluating or positioning Korean/Asian IVD manufacturers for US/Global partnerships is a massive plus. Engagement Milestones We anticipate structuring this engagement around clear deliverables across three main phases: Milestone 1: Strategic Audit & Targeting (Weeks 1–4) Conduct a blunt, honest assessment of our pitch deck, clinical data, and IP. Identify critical gaps we must close prior to buyer outreach. Formulate realistic valuation models and deliver a prioritized target list of named BD executives. Milestone 2: Warm Outreach & Positioning (Months 2–4) Leverage your existing network to secure introductory meetings with Tier-1 BD targets. Tailor our narrative to match specific buyer priorities, coach our executive team for initial meetings, and guide the preparation of our data room. Milestone 3: Negotiation & Structuring (Months 4–6+) Partner with our legal and IP teams to navigate term sheets. Provide strategic advice on exclusivity and deal structures, and ideally manage a competitive multi-bidder process. What We Provide You will have direct, unfettered access to our founders and executive suite. Under a mutual NDA, we will grant full access to our data room, including financials, manufacturing specs, IP, clinicals, an existing competitive analysis, and our FDA roadmap. Application Requirements We prioritize targeted, high-quality applications over volume. Generic, copy-pasted, or AI-generated proposals will be immediately discarded. In your cover letter, please explicitly provide: 1. Your Top Deal: Highlight ONE standout IVD rapid test/multiplex transaction you helped close. Include your specific role, the companies involved, the deal size, and the outcome. 2. Your Network: List the Tier-1 diagnostic companies where you hold current, warm BD relationships. 3. Market Read: Briefly share your perspective on the 2026 M&A and licensing landscape for the IVD sector.